NiveshIQ
Sanofi India Ltd.
NiveshIQ has detected 5 active signals on SANOFI. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Sanofi India Ltd.
Sanofi India Limited, a subsidiary of Hoechst GmbH, manufactures and trades pharmaceutical products across India, Singapore, and internationally, focusing on therapeutic areas such as diabetes, cardiology, anti‑infectives, and CNS. The company’s portfolio includes high‑profile brands like Lantus, Toujeo, Soliqua, Clexane, and Amaryl, which are distributed through independent channels and exported globally. In Q1, Sanofi Consumer Healthcare India reported a net profit of ₹688 cr, up from ₹607 cr YoY, reflecting robust demand for its consumer health products. Recent developments include the discontinuation of several eczema candidates, such as Amlitelimab, and a strategic shift away from the OX40 class, while the broader Sanofi group has raised its outlook following Dupixent sales surpassing
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,851 Cr -27.20% | ₹2,013 Cr -29.39% | ₹1,837 Cr -8.73% |
| EBITDA Margin | 28.19% | 24.38% | 26.74% |
| Net Profit | ₹602.90 Cr -11.40% | ₹413.30 Cr -31.45% | ₹326.70 Cr -20.95% |
| EPS | ₹261.78 | ₹179.46 | ₹141.85 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Strategic Outlook
- Q2FY27 results: revenue ₹492 Cr, PAT ₹117 Cr, EPS ₹50.67, EBITDA margin 32.8%. Growth context: revenue YoY +3.4%, PAT YoY +53.6%, revenue QoQ +12.3%, PAT QoQ +39.8%.
Recent corporate activity highlights product launches, approvals, and therapy-mix improvement and order wins, deal pipel...
FY26 (last completed FY): revenue ₹1, 837 Cr, PAT ₹327 Cr, EBITDA margin 26.7%, EPS ₹141.85. Year-on-year: revenue YoY -...
More Healthcare stocks
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sanofi India Ltd.?
NiveshIQ detects active intelligence signals for Sanofi India Ltd. (SANOFI) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sanofi India Ltd.?
Sanofi India Ltd. operates in the Healthcare sector with a market capitalisation of ₹775,279.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.